Clinical Trial Update: Insulin Analogue With Continuous Glucose Monitoring System (CGMS) Measurement [Phase 4]

View source ↗

Summary

Phase 4 study evaluating an insulin analogue with continuous glucose monitoring in adults with Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin analogue (insulin analogue)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus Type 2 | Phase 4 | Status: COMPLETED